MRC Clinical Trials Unit at UCL
Menu
Home
About
Our Structure
Our People
History
'25 at 25' series
Our Environmental Commitment
News
Research
Cancer
Add-Aspirin
ARCHERY
RAMPART
REFINE
STAMPEDE
STAMPEDE2
STOPCAP M1
UKCTOCS
PATCH
Open studies
Past Studies
Infections
Studies by Research Area
Neurodegenerative Diseases
ACORD collaboration
MRC Clinical Trials Unit ACORD Fellows Academy
OCTOPUS
EJS ACT-PD
Methodology
Design
Conduct
Analysis
Meta-analysis
Software
Other Research & Policy
Data Sharing
Publications
Studies in other areas
Briefing Papers
Regulatory information, Toolkits & Templates
Our podcast
Studies
All Studies
Studies Search
Patients & Public
About Clinical Trials
What is a clinical trial?
What is a randomised clinical trial?
What is an observational study?
How do we make sure a trial is safe?
How is a trial designed and run?
What happens at the end of a trial?
Taking Part in a Clinical Trial
How can you take part in a trial?
What questions should you ask before participating in a trial?
Patient and Public Involvement
About our PPI group
Our PPI Strategy
PPI Resources
Study & Careers
Capacity Strengthening
Enhancing skills of trial teams we work with across the globe
Improving the clinical trials ecosystem
NIHR Associate Principal Investigator (PI) Scheme
Contact
Search the site
Home
Posters
Strategies for maintaining double-blinding when including treatments with different modalities in multi-arm multi-stage trials: what works?
